Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Poet blijft toch wel sterk liggen in een dalende markt. Typisch voor een tech aandeel: Weinig sentiment en rationele investeerders
Ik had al een sterk gevoel in dit aandeel Dat dendert maar door alles heen
Aandelen op de TSX.V & OTC hebben in 't algemeen weinig last van wat er gebeurt op de big boards. Tijdens de ergste vlagen van de voorbije crisissen is er veel geld uit de OTC gevloeid maar onderliggende aandelen die goed nieuws uit brachten deden het toch naar behoren. POET zit nu in die positie. Lang verwacht nieuws is uitgekomen en de aanloop daar naartoe deed de prijs al rijzen, terwijl de big board stocks het moeilijk hadden. Het zelfde gebeurt nu ook weer. Er is geen noemenswaardig nieuws uitgekomen in de laatste weken en toch staan we weer zo hoog als in de vorige run. We weten dat er positief nieuws zit aan te komen en niemand wil echt de boot missen. Er is weinig verkoop op de bid, en als er al is, wordt iedere poging om 't aandeel naar beneden te krijgen gecounterd met snelle aankopen die de prijs weer opdrijven. De spread vandaag was 4 cent, van 1.46 tot 1.50. Het zal even knabbelen worden want er zit een groot order te wachten op 1.50. Alhoewel daar al een flink stuk is uitgebeten. Vanochtend stonden er 380k aandelen en nu nog 177k. Dit is een sterk teken IMO. Normaal gezien zijn traders schuw om aan zo'n muur te knagen maar nu is 't vertrouwen toch groot genoeg om te happen. Hopelijk is het geen ijsberg-order, of worden er niet teveel Warrants geconverteerd. Indien dit niet gebeurt denk ik dat we langzaam naar de 1.60 zullen gaan in afwachting van het Pellegrino rapport.
Het Jaar rapport is uitgekomen. Veel lees plezier ;)www.sedar.com/DisplayCompanyDocuments...
The Company has working capital of $3,272,349 as of December 31, 2013 compared to working capital of $1,433,392 as of December 31, 2012. Subsequent to December 31, 2013, the Company successfully completed an equity financing of $5,000,000. Additionally, the Company received $2,834,513 from the exercise of warrants. The Company is in a favorable cash position to cover its operating and investing activities and settle its outstanding obligations as they come due over the next twelve to eighteen months. ;)
Share Structure: Authorized Shares: Unlimited (No misuse, check the past) Shares Outstanding ao Apr, 04, 2014: 148,335,985 Balance of Warrants OS Apr, 04, 2014: 34,716,706 Balance of Options OS, Apr, 04, 2014: 23,832,750 Fully Diluted shares, Apr, 04, 2014: 206,885,441 Float on OTC Markets., Jun 23, 2013: 124,805,100 My own calculation of the Float ao Apr, 04, 2014: Common shares held by Insiders (+ Piney) 18,322,563 Shares Outstanding 148,335,985 - 18,322,563 = 130,013,422Share Ownership As of December 15, 2013, there were a total of 1,016 holders of record of our common shares, of which 470 were registered with addresses in the U.S. We believe that the number of beneficial owners is substantially greater than the number of record holders, because a large portion of our common shares are held of record in broker “street names.” As of December 31, 2013, U.S. holders of record held approximately 3.3% of our outstanding common shares. There are 28,374,000 Class A Common Shares of OPEL Solar, Inc. issued and outstanding. There are 5 Common Shares of ODIS Inc. issued and outstanding, held by OPEL Solar, Inc. University of Connecticut owns: 2 Million shares (restricted until May 31, 2016) POET TECHNOLOGIES INC. ("PTK") BULLETIN TYPE: Property-Asset or Share Purchase Amending Agreement BULLETIN DATE: February 21, 2014 TSX Venture Tier 2 Company TSX Venture Exchange has accepted for filing documentation relating to a term sheet (the "Amended Agreement") dated February 7, 2014 between the University of Connecticut ("UCONN") and OPEL Solar, Inc. ("Subco"), a wholly owned subsidiary of POET Technologies Inc. (the "Company"). Pursuant to the Amended Agreement, the Company will issue 2,000,000 shares to UCONN as consideration for amending certain terms of their original license agreement. For more information, refer to the Company's news release dated February 11, 2014.www.newswire.ca/en/story/1311135/tsx-... Commons Shares held current insiders of POET: March 24, 2014: 18,322,563 Options Shares held current insiders of POET: March 24, 2014: 18,053,750 Warrant Shares held current insiders of POET: March 24, 2014: 13,616,385 Maximum Number of stock Options is currently fixed at 26,475,000. The weighted average exercise price of warrants is CA$0.48. The weighted average exercise price of issued and outstanding options is CA$0.397. As at December 31, 2013 the following warrants were outstanding: ..Number of Warrants:...Historical Fair Value..Exercise ($) Price......($) Expiry Date Warrants....1,295,558.................279,660................0.29........July 21, 2014 Warrants....2,157,348.................284,635................0.34.........June 8, 2015 Warrants....2,770,044.................365,143................0.34........June 22, 2015 Warrants....1,554,000.................208,972................0.34........July 31, 2015 Warrants....6,272,087.................856,893................0.34....September 7, 2015 Warrants....5,369,000.................744,240................0.34...September 13, 2015 Warrants....5,000,000.................687,082................0.35...September 27, 2015 Warrants.. 14,400,000...............3,825,178................0.75....February 14, 2015 C warrants....220,734..................38,642................0.22.........June 8, 2016 C warrants....285,289..................49,943................0.22........June 22, 2016 C warrants....155,400..................27,708................0.22........July 31, 2016 C warrants....522,209..................94,597................0.22....September 7, 2016 C warrants....536,900..................98,681................0.22...September 13, 2016 C warrants....500,000..................91,102................0.22...September 27, 2016 C warrants..1,440,000.................483,114................0.50....February 14, 2016 C = Compensation Balance on 31/12/2013 = 42,478,569 Subsequent to the year end, the Company received CAD $2,834,513 from the exercise of 7,761,863 warrants. 42,478,569 - 7,761,863 = 34,716,706 on 04/04/2014.Institutional Ownership: Common Shares of Sheldon Inwentash: Common Shares: 1,517,000 Pinetree Capital Ltd (Identity #00004131): Common Shares: 10,000,785 Pinetree Capital Self Directed RRSP of Sheldon Inwentash: Common Shares: 4,912,500 Warrants of Sheldon Inwentash: Warrants: 1,000,000 Warrants Pinetree Capital Ltd: 7,775,385 Warrants Self Directed RRSP of Sheldon Inwentash: 4,696,000 Total Holdings of Sheldon Inwentash/Pinetree Capital Ltd: 29,326,270 - ISHARES S&P/TSX VENTURE INDEX FUND: 41,404www.stockwatch.com/Fund/Targeted.aspx... - William White (IBK Capital) & his wife hold 8,883,500. See page 52 & 53 of the 20FR12G file with the SEC:www.sec.gov/Archives/edgar/data/14374... * IBK Capital has funded a total of $39,046,152 since inception of the company.www.ibkcapital.com/financings/ Canada Insider Trading of latest 6 months:www.canadianinsider.com/node/7?menu_t... To see All the Company Insiders, go to: www.sedi.ca/ Select Language --> Reports --> Click "Access public filings" --> Click on View Summary Reports --> Select "Insider information by issuer" --> Under "Mandatory criteria:" Select "Issuer Number" & Enter "00003983" Click on "View" to see all the results. PS: Note that once Directors cease to be an insider the SEDI reports are all but useless for those insiders. Because they can buy/sell after the cease date and those transactions will never show up in a public reporting database like SEDI. So there is no guarantee that any of the past Directors currently hold the shares that are visible on SEDI. * * * * * * * * * * * * * * * *
The Company incurred substantial legal and accounting fees related to the preparation and filing of Form 20-F with the U.S. Securities Exchange Commission (“SEC”). Legal fees relating to this SEC filing were $170,000 and accounting fees were $36,000. The filing of the Form 20-F occurred in February 2014 and was the first step in the Company’s plan to register the Company’s securities on a U.S. exchange. If successful, it is anticipated that this would result in more liquidity for the Company’s shares, access to other capital markets and greater visibility to prospective partners during the process of monetization. There can be no assurances that the Company’s shares will be registered on a U.S. exchange.
nobahamas schreef op 4 april 2014 22:06 :
Poet blijft toch wel sterk liggen in een dalende markt.
Typisch voor een tech aandeel:
Weinig sentiment en rationele investeerders
Valt me op dat jullie (jij, Europeaan, veer, doewap etc.) dit aandeel benaderen vanuit een technicals of pump/hype perspectief. Ben benieuwd of jullie al eens hebben gekeken naar de techniek en personen die hier in betrokken zijn? Voor mij is dit (voor zover ik dit kan zien) een blijvertje en alsof ik Intel of Microsoft kan kopen toen ze nog klein en onbekend waren. Geen garanties dat dit bedrijf tevens succesvol zal zijn, maar in mijn ogen zal het dan niet aan de achterliggende techniek liggen. En meer aan de complexiteit van de bedrijfsvoering (besturen en alle processen efficiënt en effectief naast elkaar laten lopen) en om een dergelijke breed toepasbare techniek de markt op te krijgen en de markt er van te overtuigen dat dit echt DE oplossing is (op de korte tot middellange termijn).
Je hebt gelijk Solesius ... een goed product is 1 ... maar net zo belangrijk, of zelfs nog belangrijker, is het om een markt ervan te overtuigen dat ze jou product moeten nemen. Over het algemeen zijn klanten defensief bij nieuwe technieken, en is de sales-cyclus lang. Ik zeg dit in zijn algemeenheid, niet specifiek op POET gericht.
Solesius schreef op 5 april 2014 15:35 :
[...]
Valt me op dat jullie (jij, Europeaan, veer, doewap etc.) dit aandeel benaderen vanuit een technicals of pump/hype perspectief. Ben benieuwd of jullie al eens hebben gekeken naar de techniek en personen die hier in betrokken zijn?
Voor mij is dit (voor zover ik dit kan zien) een blijvertje en alsof ik Intel of Microsoft kan kopen toen ze nog klein en onbekend waren. Geen garanties dat dit bedrijf tevens succesvol zal zijn, maar in mijn ogen zal het dan niet aan de achterliggende techniek liggen. En meer aan de complexiteit van de bedrijfsvoering (besturen en alle processen efficiënt en effectief naast elkaar laten lopen) en om een dergelijke breed toepasbare techniek de markt op te krijgen en de markt er van te overtuigen dat dit echt DE oplossing is (op de korte tot middellange termijn).
Pump? Technicals? Buy and hold. Ik ben geen kenner van semiconductors, maar ik heb wel degelijk een beeld van de mensen die erbij betrokken zijn.
Kahoona1962 schreef op 5 april 2014 16:01 :
Je hebt gelijk Solesius ... een goed product is 1 ... maar net zo belangrijk, of zelfs nog belangrijker, is het om een markt ervan te overtuigen dat ze jou product moeten nemen. Over het algemeen zijn klanten defensief bij nieuwe technieken, en is de sales-cyclus lang.
Ik zeg dit in zijn algemeenheid, niet specifiek op POET gericht.
Yep, er zijn (gelukkig) wel omstandigheden die in het voordeel werken van POET. Er zijn talloze artikelen verschenen over het einde van moore's law, de (gigantische) kosten van bestaande innovatie in sillicium (meer dan 10 miljard voor <10 nm), om de POET chips te maken dienen huidige fabrieken 'minimaal' omgebouwd te worden en kan het worden gedaan met bestaande mapparatuur en met een chip is het vrij 'eenvoudig' om aan te tonen dat deze superieur is. Je sluit er maeetapparatuur op aan en hij is wel of niet sneller, zuiniger etc.
POET Technologies Announces Completion and Availability of POET Technology Design Kit Documentation (POET/TDK) TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - April 7, 2014) - POET Technologies Inc. (TSX VENTURE:PTK)(OTCQX:POETF) ("the Company") - developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced the availability of the POET Technology Design Kit (POET/TDK) documentation to the industry. POET/TDK POET/TDK provides complete documentation for the entire catalog of active electronic and electro-optical devices currently supported by the POET process. It comprises a comprehensive device parameter library, and enables potential customers and partners - including semiconductor foundries and device and library developers - to implement the POET process. As usage grows, POET/TDK is also expected to help licensed designs in a POET device ecosystem to proliferate, and help existing complementary metal-oxide semiconductor (CMOS) silicon library functions optimize migration time to POET designs. Mr. Peter Copetti, Executive Chairman and interim CEO, noted, "Completion of the POET/TDK marks a critical step towards commercialization and monetization of the Company's intellectual property. We're extremely excited to be able to showcase our game-changing technology to potential customers and partners in a context specific to their own manufacturing framework." While POET devices have already been successfully manufactured and validated at a third-party foundry without using POET/TDK, its availability now makes such technology migration much easier in the future. POET/TDK and associated information is shared only under non-disclosure agreements (NDA) with current and potential partners and customers for the express purpose of evaluation of and migration to the POET platform. TCAD Simulation of Processes and Devices Based on the TDK, Company staff and its tool partner are currently using technology computer-aided design (TCAD) simulation to develop and optimize specific semiconductor processing technologies and devices of interest to other potential partners. Mr. Copetti added, "It's remarkable that the completion of the TDK and the TCAD work with our tools partner was achieved by our team - Dr. Geoff Taylor, Lee Shepherd and the POET team at the University of Connecticut - in parallel with significant strides in our 100-nm milestone, and research on the possibility of POET-based quantum computing devices. We've set challenging milestones for ourselves, and expect to continue to meet these challenges in our drive towards our 'Powered by POET' vision." The TCAD effort is geared towards developing the models necessary to enable POET's technology into an industry-standard design tool-flow. This design tool-flow is required to evaluate and ultimately transfer POET's technology into manufacturers' design-and-fabrication environments. PET Advances Specific TCAD efforts are focused on complementary hetero-structure field-effect transistors (HFETs) and bipolar transistors (HBTs), which form the basis for the first TDK release focused on the planar electronic technology (PET), the electrical subset of the POET process. It can support complementary HFET (CHFET), bi-CHFET, bipolar and thyristor device fabrication. PET offers lower cost and simpler process fab options for applications that do not require the full optical feature set offered by POET. All of the electronic devices of the PET platform represent a breakthrough in performance and power efficiency over existing silicon CMOS technologies that exist today and on the industry roadmap. The PET/TDK models are anticipated to be available to third parties around the end of the third quarter 2014. By enabling increased speed, density, reliability, power efficiency, and much lower bill-of-materials and assembly costs, the POET semiconductor platform is expected to provide disruptive performance with an industry-compatible transition framework, and positions the Company as a leader in the new generation of companies defining the growth paradigm in the post-Moore's Law world.
Bijna al een miljoen aandelen al verhandeld
Mooi nieuws en right on time
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
903,61
-0,22%
EUR/USD
1,0834
+0,00%
FTSE 100
8.275,38
+0,54%
Germany40^
18.585,90
+0,48%
Gold spot
2.327,41
0,00%
NY-Nasdaq Composite
16.735,02
-0,01%
Stijgers
Dalers